VITALE, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.779
AS - Asia 4.002
EU - Europa 3.782
SA - Sud America 560
Continente sconosciuto - Info sul continente non disponibili 103
AF - Africa 87
OC - Oceania 7
Totale 18.320
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.619
GB - Regno Unito 1.444
SG - Singapore 1.213
CN - Cina 1.117
IT - Italia 659
VN - Vietnam 445
HK - Hong Kong 441
BR - Brasile 431
SE - Svezia 356
DE - Germania 306
BD - Bangladesh 196
FR - Francia 177
UA - Ucraina 165
FI - Finlandia 164
RU - Federazione Russa 163
KR - Corea 111
IN - India 99
TR - Turchia 97
IE - Irlanda 88
CA - Canada 87
BG - Bulgaria 68
AR - Argentina 40
ID - Indonesia 36
MX - Messico 34
IQ - Iraq 30
NL - Olanda 30
AE - Emirati Arabi Uniti 29
JP - Giappone 29
ZA - Sudafrica 29
ES - Italia 24
PK - Pakistan 24
CO - Colombia 21
MY - Malesia 21
BE - Belgio 19
PL - Polonia 19
CL - Cile 18
VE - Venezuela 18
EC - Ecuador 17
BY - Bielorussia 15
UZ - Uzbekistan 13
PH - Filippine 12
SA - Arabia Saudita 12
LT - Lituania 10
CZ - Repubblica Ceca 9
MA - Marocco 9
PT - Portogallo 9
PY - Paraguay 9
CR - Costa Rica 8
EG - Egitto 8
NP - Nepal 8
TH - Thailandia 8
AT - Austria 7
AZ - Azerbaigian 7
RO - Romania 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
AL - Albania 6
DO - Repubblica Dominicana 6
KE - Kenya 6
KZ - Kazakistan 6
AU - Australia 5
DZ - Algeria 5
GE - Georgia 5
HU - Ungheria 5
IL - Israele 5
JO - Giordania 5
CH - Svizzera 4
ET - Etiopia 4
JM - Giamaica 4
LB - Libano 4
LU - Lussemburgo 4
NO - Norvegia 4
PS - Palestinian Territory 4
SI - Slovenia 4
TW - Taiwan 4
BO - Bolivia 3
CY - Cipro 3
GR - Grecia 3
HN - Honduras 3
LY - Libia 3
MM - Myanmar 3
NG - Nigeria 3
OM - Oman 3
PA - Panama 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AM - Armenia 2
CG - Congo 2
CI - Costa d'Avorio 2
DK - Danimarca 2
EE - Estonia 2
GT - Guatemala 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
NI - Nicaragua 2
PR - Porto Rico 2
SC - Seychelles 2
UY - Uruguay 2
Totale 18.201
Salva come PNG Salva come JPEG
Città #
Southend 1.111
Ashburn 979
Santa Clara 845
Fairfield 804
Singapore 765
Woodbridge 562
Chandler 464
Hong Kong 428
Houston 409
Hefei 366
Seattle 360
Jacksonville 347
San Jose 304
Wilmington 292
Dearborn 291
Cambridge 290
Ann Arbor 288
Chicago 248
Los Angeles 235
Beijing 230
Nyköping 201
London 163
Council Bluffs 156
Ho Chi Minh City 126
New York 125
The Dalles 118
Modena 116
Helsinki 101
Hanoi 96
Seoul 93
Salt Lake City 91
Dublin 85
Dallas 78
Princeton 75
San Diego 67
Milan 66
Sofia 64
Buffalo 61
Eugene 57
Izmir 53
Lauterbourg 51
Moscow 48
Toronto 44
Elk Grove Village 42
Des Moines 41
São Paulo 40
Frankfurt am Main 36
Longmont 33
Bremen 32
Boardman 30
Munich 30
Tampa 30
Orem 29
Redwood City 28
Fremont 27
Tokyo 27
Phoenix 26
Rome 26
Columbus 24
Falls Church 24
Lancaster 24
Chennai 23
Da Nang 23
Haiphong 22
Atlanta 21
Brooklyn 21
Shanghai 21
Sterling 21
Miami 20
Bologna 19
Springfield 19
Denver 18
Brussels 17
Norwalk 17
Warsaw 16
Jakarta 15
Johannesburg 15
Naples 15
Ferrara 14
Pittsburgh 14
Detroit 13
Mexico City 13
Parma 13
Seongnam 13
Boston 12
Montreal 12
Tashkent 12
Amsterdam 11
Biên Hòa 11
Kansas City 11
Las Vegas 11
Paris 11
Poplar 11
Rio de Janeiro 11
San Francisco 11
Wuhan 11
Baghdad 10
Kent 10
Mumbai 10
Nanjing 10
Totale 12.880
Salva come PNG Salva come JPEG
Nome #
Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats 499
ANXIOLYTIC LIKE EFFECT OF NEUROPEPTIDE S IN THE RAT DEFENSIVE BURYING. 493
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 437
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 431
Acute noise stress analgesia in relation to 5-HT2 and mu-opioid receptor changes in the frontal cortex of young mice 421
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats 398
Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating. 387
Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet 382
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. 378
Effects of [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 364
CCAP regulates feeding behavior via the NPF pathway in Drosophila adults 364
Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol 363
Differential involvement of opioidergic and serotoninergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol 360
Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats 360
Collagen VI regulates peripheral nerve regeneration by modulating macrophage recruitment and polarization 358
[tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies. 343
Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation. 335
BRAIN-SEROTONIN BINDING-CAPACITY, ANALGESIA AND DRUG SERUM LEVELS AFTER ACUTE TREATMENT WITH PHENAZONE IN RATS 315
Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system 314
Gamma-hydroxybutyrate increases gastric emptying in rats 314
Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes 312
Structure Model and Toxicity of the Product of Biodissolution of Chrysotile Asbestos in the Lungs 308
Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain 304
Serotonergic and opiatergic modifications induced by paracetamol as a model for daily chronic headache with analgesic overuse 303
Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test 302
Effect of rofecoxib on nociception and the serotonin system in the rat brain 291
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials 287
Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain. 286
In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505 278
Disposition of naproxen after oral administration during and between migraine attacks. 273
BV-2 Microglial Cells Respond to Rotenone Toxic Insult by Modifying Pregnenolone, 5alpha-Dihydroprogesterone and Pregnanolone Level 273
In vitro toxicity of fibrous glaucophane 268
Headaches associated with chronic use of analgesics: A therapeutic approach 267
Acetylsalicyclic acid potentiates the antinociceptive effect of morphine in the rat:involvement of the central serotonergic system. 266
Disclosing the Antioxidant and Neuroprotective Activity of an Anthocyanin-Rich Extract from Sweet Cherry (Prunus avium L.) Using In Vitro and In Vivo Models 261
THE ROLE OF SEROTONIN BRAIN RECEPTORS IN THE ANALGESIC EFFECT OF PHENAZONE 257
Effects of chronic treatment with phenazone on the hot plate test and [3H]-Serotonin binding sites in pons and cortex membranes of the rat 255
Acute cytotoxicity of mineral fibres observed by time-lapse video microscopy 255
Human microglia synthesize neurosteroids to cope with rotenone-induced oxidative stress 254
The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain 254
PHYSIOLOGICAL-PARAMETERS AND PLASMA-LEVELS AFTER SHORT AND LONG-TERM PROPOFOL INFUSION 253
Lack of activity of Ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats 249
The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain. 243
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 241
Glutamate-mediated astrocyte-to-neuron signaling in the rat dorsal horn 241
Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid 240
The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain 238
The effect of chronic treatment with phenazone on [3H]-serotonin binding sites in pons and cortex membranes of the rat 235
Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain 234
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain 228
Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat 220
Plasma reduced glutathione level and changes in thiol groups after glutathione administration in drug abuser patients - 214
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 213
Naloxone-reverisble antinociception by paracetamol in the rat. 207
Plasma time-course of naltrexone and 6beta-naltrexol after oral naltrexone administration in patients with liver cirrhosis 207
EFFECTS OF ACETYLSALICYCLIC ACID ON SEROTONIN BRAIN RECEPTOR SUBTYPES 200
Chronic treatment with phenazone modifies pontine noradrenergic receptors in rats. 198
Effect of hypericum perforatum extract in an experimental model of binge eating in female rats 191
Naltrexone and 6-Beta-naltrexol concentration/time profile in the treatment of opiate dependence 178
Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study 175
Lack of activity of azapropazone in the hot-plate test and in 5-HT1A and 5-HT2 receptor subtypes in rat brain membranes 174
Serum levels of naltrexone and 6-beta-naltrexol after oral naltrexone in patients with liver cirrhosis 161
Plasma time-course of naltrexone and 6beta-naltrexol levels after oral administration in drug addicts and in patients with liver cirrhosis 149
Chemical Characterization and Beneficial Effects of Walnut Oil on a Drosophila melanogaster Model of Parkinson’s Disease 137
Characterization of Walnut Oil and Evaluation of Its Neuroprotective Effects in an In Vitro Model of Parkinson’s Disease 124
Totale 18.320
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.162
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.278 0 156 157 76 37 37 101 64 148 99 257 146
2022/20231.341 163 152 86 124 147 207 22 118 137 30 55 100
2023/2024650 36 36 49 54 162 43 34 93 11 17 52 63
2024/20252.692 86 16 44 176 566 388 225 136 298 160 293 304
2025/20266.379 405 273 437 779 1.126 448 648 297 598 523 463 382
2026/2027274 250 24 0 0 0 0 0 0 0 0 0 0
Totale 18.320